However, the slight increase in GATA3 and IL‐4 in probiotic‐treated groups suggests potential subtle effects on Th2 pathways, which warrant further investigation, particularly in contexts where Th2 responses may play a secondary role, such as in lupus nephritis (An et al. 2022). The gene discussed is GATA3; the disease is lupus nephritis.